The international organisation Alström Syndrome International (ASI), with whom we work closely, has published a new science and research press release.
In it, ASI announces a partnership with Alstara and presents a research roadmap for the next few years – the priorities it will focus on so that new treatment options reach patients as soon as possible.
We will keep you informed about the concrete next steps.
Source: ASI – Research & Science Update
